Aphria: Consensus Estimates For Q3 2021

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expected to report their fiscal third quarter on April 12th. Analysts have a consensus C$17.72 12-month price target on the company, via a total of ten analysts, with two analysts have strong buy ratings. Five analysts have buy ratings and three have hold ratings. The street high comes from Cantor Fitzgerald with a C$32.50 price target, and the lowest target comes is a C$7 price target.

Seven analysts have revenue estimates for the third quarter. The mean between all 7 is C$170.66 million; this number has been revised downwards from C$175.58 million at the start of the year. The highest revenue estimate is C$182.90 million, while the lowest is C$152 million.

Onto EBITDA estimates, there are currently seven analysts who have third-quarter EBITDA estimates. The mean is currently C$14.46 million, with this number having been revised down from C$18.97 million at the start of the year. Street high is C$21.70 million EBITDA estimate and the lowest being C$6 million.

Analysts estimate that quarterly earnings per share will come in at negative C$0.03, with this number being revised down from negative C$0.01 at the start of the year. Street high is break-even and the lowest estimate is negative C$0.05 for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

Beyond Meat: Analysts Lower Price Targets Following Disappointing Earnings

Beyond Meat (NASDAQ: BYND) has been a laggard this year, with its year-to-date performance currently...

Sunday, May 16, 2021, 02:13:00 PM

Trulieve: Five Analysts Raise Price Targets Following Stellar Earnings

Trulieve Cannabis (CSE: TRUL) reported their second-quarter financial results this week, boasting a record U$120.8...

Friday, August 14, 2020, 11:43:41 AM

Haywood Reiterates $12 Price Target On Well Health

On January 20th, Well Health (TSX: WELL) provided a business update which included fourth quarter...

Monday, January 24, 2022, 04:22:00 PM

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM

Jushi: Canaccord Raises Estimates Following Nature’s Remedy Acquisition

On September 13th, Jushi Holdings (CSE: JUSH) announced that they completed their acquisition of Nature’s...

Wednesday, September 15, 2021, 10:58:00 AM